Benzodiazepine Group (Oxazepam/Clonazepam) ELISA (Enzyme-Linked Immunosorbent Assay) kit is a qualitative kit designed for use as a screening test for the detection of Benzodiazepine and/or their metabolites. Benzodiazepine Group offers ultra-sensitive detection of more than 20 benzodiazepines, including phenazepam, etizolam, delorazepam, diclazepam, pyrazolam, flubromazepam, alprazolam, lorazepam, clonazepam, diazepam, temazepam, cloniprazepam, flubromazolam, and clonazolam. The kit was designed for screening purposes and is intended for forensic use only.

Specifications
Brand	Neogen®
Analyte	Oxazepam, Benzodiazepine Group
Application	Urine, Blood, Oral Fluid, Breast Milk, Forensic Matrices
Intended Use	For the determination of trace quantities of Benzodiazepine and/or other metabolites in human urine, blood or oral fluid. Contact a Neogen representative for information on other matrices.
Species	Human, Research Animal
Assay Sample Size	10 µL
Platform	ELISA
Result Type	Qualitative
Microplate Size	96 well microplate
Sensitivity	Compound I-50 in EIA Buffer Oxazepam 5.81 ng/mL The term I-50 is used to define the sensitivity of the test. This number is derived from a standard curve generated with the drug in EIA Buffer. The drug concentration that shows 50% less color activity than the zero standard is considered to be the I-50.
Total Assay Incubation Time	75 minutes
Drug Panel	Antidepressants/Sedatives, Workplace Testing
Storage Conditions	2-8°C
Wavelength	450 nm with acid stop
Package Dimensions	7.50 in x 5.00 in x 4.00 in
Package Weight	0.80 lb